{"schema_version":"1","generated_at":"2026-11-21T17:42:47.169Z","data_as_of":null,"url":"https://www.findmykol.com/kol/janak-goyal","json_url":"https://www.findmykol.com/kol/janak-goyal/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"janak-goyal","name":"Janak Goyal","credential":"MD","specialty":"Rheumatology","specialty_raw":"Rheumatology","therapeutic_area":"Rheumatology/Immunology","therapeutic_areas":["Rheumatology/Immunology"],"institution":"Raritan Bay Medical Center","institution_url":"https://www.findmykol.com/institution/raritan-bay-medical-center","city":"Perth Amboy","state":"NJ","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"on_file":["npi","openalex"],"values":"Shown on the profile page to a signed-in account."},"summary":"Janak Goyal is a Rheumatology/Immunology physician affiliated with Raritan Bay Medical Center. OpenAlex indexes 10 publications with 213 citations (h-index 6).","overview":null,"focus":{"indications":[],"research_topics":["Rheumatology/Immunology"]},"scholarship":{"works_count":10,"cited_by_count":213,"h_index":6,"latest_activity_year":2023,"source":"works"},"payments":{"company_count":4,"program_years":{"first":2021,"last":null},"rows_total":4,"shown":3,"withheld":1,"rows":[{"payer":"ANI Pharmaceuticals, Inc.","program_year":2023,"amount_usd":121.54,"payment_count":1},{"payer":"Aurinia Pharma U.S., Inc.","program_year":2022,"amount_usd":14.07,"payment_count":1},{"payer":"E.R. Squibb & Sons, L.L.C.","program_year":2021,"amount_usd":42.59,"payment_count":3}],"source":"payments"},"prescribing":{"data_year":2023,"areas_total":4,"areas_shown":3,"areas":[{"area":"Metabolism & gastrointestinal","share_pct":39.9,"classes_total":2,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":33.3,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":19},{"class":"Proton pump inhibitor","setting":"prescribed","share_pct":6.6,"drugs":[{"name":"Omeprazole","share_pct":100}],"max_beneficiaries":null}]},{"area":"Cancer & immunology","share_pct":38,"classes_total":3,"classes":[{"class":"Folate Analog Metabolic Inhibitor","setting":"prescribed","share_pct":16.9,"drugs":[{"name":"Methotrexate","share_pct":100}],"max_beneficiaries":16},{"class":"TNF inhibitor","setting":"prescribed","share_pct":14.6,"drugs":[{"name":"Enbrel Sureclick","share_pct":64.5},{"name":"Humira(Cf) Pen","share_pct":35.5}],"max_beneficiaries":null}]},{"area":"Nervous system","share_pct":12.7,"classes_total":1,"classes":[{"class":"SNRI","setting":"prescribed","share_pct":12.7,"drugs":[{"name":"Duloxetine Hcl","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2023,"office_pct":100,"facility_pct":0},"source":"medicare"},"publications":{"total":10,"shown":5,"withheld":5,"matched_by":"OpenAlex author record","recent":[{"title":"Similar Improvements in Patient-Reported Outcomes Among Rheumatoid Arthritis Patients Treated with Two Different Doses of Methotrexate in Combination with Adalimumab: Results From the MUSICA Trial","year":2018,"journal":"Rheumatology and Therapy","source_url":"https://doi.org/10.1007/s40744-018-0105-7","status":"verified"},{"title":"Changes in Ultrasonographic Vascularity Upon Initiation of Adalimumab Combination Therapy in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate","year":2016,"journal":"Arthritis & Rheumatology","source_url":"https://doi.org/10.1002/art.39751","status":"verified"},{"title":"Review Article Imaging Appearances in Gout","year":2016,"status":"verified"},{"title":"FRI0077 The Use of Ultrasound to Detect Residual Joint Inflammation in Patients with Rheumatoid Arthritis in Clinical Disease Remission","year":2015,"journal":"Annals of the Rheumatic Diseases","source_url":"https://doi.org/10.1136/annrheumdis-2015-eular.1216","status":"verified"},{"title":"FRI0238 Changes in Ultrasonographic Vascularity upon Initiation of Adalimumab Combination Therapy in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate","year":2014,"journal":"Annals of the Rheumatic Diseases","source_url":"https://doi.org/10.1136/annrheumdis-2014-eular.1389","status":"verified"}],"source":"works"},"similar":[{"name":"Ira Spiler","slug":"ira-spiler","institution":"Raritan Bay Medical Center","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/ira-spiler","json_url":"https://www.findmykol.com/kol/ira-spiler/profile.json"},{"name":"David Felson","slug":"david-felson","institution":"Boston University","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/david-felson","json_url":"https://www.findmykol.com/kol/david-felson/profile.json"},{"name":"Marc Hochberg","slug":"marc-hochberg","institution":"University of Maryland School of Medicine","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/marc-hochberg","json_url":"https://www.findmykol.com/kol/marc-hochberg/profile.json"},{"name":"Philip Mease","slug":"philip-mease","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/philip-mease","json_url":"https://www.findmykol.com/kol/philip-mease/profile.json"},{"name":"Michelle Petri","slug":"michelle-petri","institution":"Johns Hopkins University School of Medicine","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/michelle-petri","json_url":"https://www.findmykol.com/kol/michelle-petri/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":1,"publications":5}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}